Beth L. Carlson, RPAC

Beth Carlson practices at Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York.

Beth Carlson's NPI, 1346351749, was assigned on August 31, 2006. Beth Carlson holds New York license 010023.

Beth Carlson's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD, at 1000 South Ave, Rochester, NY 14620.

Beth Carlson's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York. Beth Carlson is also affiliated with Highland Hospital. The medical group on file is Highland Hospital. Dmand AI also links Beth Carlson to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Beth Carlson practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical is Beth Carlson's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Beth Carlson is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Beth Carlson is licensed in New York.

CMS data shows 30 Medicare services from Beth Carlson across 1 procedure code in 2024, for 25 Medicare patients. Medicare paid $964 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 25 Medicare patients who saw Beth Carlson in 2024. The largest group is 75 to 84, with 11 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Beth Carlson's median patient age at 68, with 54% women.

In 2024, Beth Carlson wrote 180 Medicare Part D claims for 93 patients. 65% of them were for generic drugs. CMS names the drug for 102 of them, across 4 drugs with 11 or more claims each, at $1,387 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Beth Carlson for performance year 2024, reported as part of a group. Beth Carlson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Beth Carlson from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $18.